Trials / Unknown
UnknownNCT02058472
Pharmacokinetic/Pharmacodynamic & Safety Study of G3041 and SEVIKAR® Tablet in Healthy Adult Volunteers
An Open Label, Randomized, Single-dose Crossover Study to Evaluate the Pharmacokinetic/Pharmacodynamic Characteristics and Safety Following Administration of G3041 and SEVIKAR® Tablet in Healthy Adult Volunteers
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Dong-A Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 19 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
Study Design : randomized, open label, single-dose, 2-way cross-over design Phase : Phase I
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | G3041 | |
| DRUG | SEVIKAR® |
Timeline
- Start date
- 2013-12-01
- Primary completion
- 2014-05-01
- Completion
- 2014-05-01
- First posted
- 2014-02-10
- Last updated
- 2014-02-10
Source: ClinicalTrials.gov record NCT02058472. Inclusion in this directory is not an endorsement.